the pros and cons of apoptosis assays for use in …...review the pros and cons of apoptosis assays...
TRANSCRIPT
Review
The Pros and Cons of Apoptosis Assays for Usein the Study of Cells, Tissues, and Organs
Michiko Watanabe,1* Midori Hitomi,1 Kathy van der Wee,2 Florence Rothenberg,2
Steven A. Fisher,2 Robert Zucker,3 Kathy K.H. Svoboda,4 Edie C. Goldsmith,5
Kaisa M. Heiskanen,6 and Anna-Liisa Nieminen6,7
1Department of Pediatrics (UHC), Case Western Reserve University, Cleveland, OH 44106, USA2Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA3Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory,
Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA4Department of Biomedical Sciences, Texas A&M Health Science Center, Baylor College of Dentistry, Dallas, TX 75246, USA5Department of Developmental Biology and Anatomy, University of South Carolina School of Medicine,
Columbia, SC 29209, USA6Department of Anatomy, Case Western Reserve University, Cleveland, OH 44106, USA7CWRU/University Hospitals Ireland Comprehensive Cancer Center, Cleveland, OH 44106, USA
Abstract: Programmed cell death or apoptosis occurs in many tissues during normal development and in the
normal homeostasis of adult tissues. Apoptosis also plays a significant role in abnormal development and
disease. Increased interest in apoptosis and cell death in general has resulted in the development of new
techniques and the revival of old ones. Each assay has its advantages and disadvantages that can render it
appropriate and useful for one application, but inappropriate or difficult to use in another. Understanding the
strengths and limitations of the assays would allow investigators to select the best methods for their needs.
Key words: cell death, confocal microscopy, immunohistological techniques, mitochondria, programmed cell
death
INTRODUCTION
In the past 10 years, there has been an extraordinary in-
crease in research aimed at understanding the mechanisms
and processes that underlie programmed cell death or apop-
tosis. This increased interest in apoptosis has arisen from
the realization that this particular form of cell death occurs
during both normal development and disease progression
and treatment ~Thompson, 1995; Anversa et al., 1997; Yaoita
and Nakajima, 1997; van den Hoff et al., 2000!. Apoptosis
can be characterized by an orchestrated series of events in
cultured cells beginning with plasma membrane blebbing
followed by extension of echinoid protrusions, plasma mem-
brane blistering, and, ultimately, cell lysis ~Collins et al.,
1997!. In tissues, the apoptotic cells or cell fragments are
phagocytosed before cell lysis with little or no immune
response.
Apoptosis is initiated by multiple triggers and regulated
by a complex network of molecules ~reviewed in Blanken-
Received July 30, 2001; accepted March 6, 2002.
Kaisa M. Heiskanen is now at the Department of Biology, Laboratory of Animal
Physiology, University of Turku, Finland.
*Corresponding author. E-mail: [email protected]
Microsc. Microanal. 8, 375–391, 2002DOI: 10.1017/S1431927602010346 MicroscopyAND
Microanalysis© MICROSCOPY SOCIETY OF AMERICA 2002
berg et al., 2000; De Laurenzi and Melino, 2000; Matsuyama
and Reed, 2000; Nicholson, 2001!. Pathways leading to
apoptosis are generally separated into two interconnected
pathways, one requiring the activation of death ligands and
receptors ~Schulze-Osthoff et al., 1998; Ashkenazi and Dixit,
1999! and another involving the mitochondria ~Waterhouse
and Green, 1999; Shi, 2001!. There is now evidence that the
two are linked and that molecules in one pathway can
influence the other. Whatever the triggering signal, the
apoptosis pathways convene on the same terminal pathway
that is initiated by the cleavage activation of Caspase-3.
Most of the commonly used apoptosis assays detect the later
events of apoptosis that occur in the terminal apoptotic
cascade ~Fig. 1!.
Apoptosis is often contrasted with necrosis. Necrosis is
associated with the explosion of cells including a rapid
degradation and increase in the permeability of the plasma
membrane, swelling of the mitochondria, and a subsequent
immune response. In contrast, apoptosis can be considered
to be the implosion of cells into compact membrane-bound
packages termed “apoptotic bodies” that are phagocytosed
by macrophages or other surrounding cells. In apoptosis,
the immune response is minimally activated although excep-
tions have been noted ~Bowen-Pope and Schaub, 2001!.
Apoptosis has also been defined as cell death involving
caspase activity and DNA fragmentation ~Haunstetter and
Izumo, 1998!. Cells also die with atypical characteristics
that make it difficult to put them in either category. New
categories have been proposed including autoschizis ~La-
tour et al., 2000; Taper et al., 2001! and parapoptosis ~Spe-
randio, 2000!. A discussion of how to categorize the various
forms of cell death and terms to refer to these cell deaths
continues ~Majno and Joris, 1995; Levin, 1999; Wyllie and
Golstein, 2001!.
One of the challenges of assaying for apoptosis is the
speed at which cells die and disappear. The time from
initiation of apoptosis to its completion can be as short as
2–3 hr ~Bursch et al., 1990a, 1990b!. In a system that is
being investigated for apoptosis for the first time, assaying
too early or too late can result in false negative findings
because the cells can die and disappear without a trace
within a few hours. Collection of data from multiple high-
resolution time points would need to be assayed to ensure
that this oversight does not occur. Another challenge is that
apoptosis can occur at low frequency or in specific sites
within cultures, tissues, or organs. An example is found in
studies of human carcinoma cells used to describe the
morphological sequence of events in apoptosis. It was dem-
onstrated that the apoptotic time course ~12–24 hr! was
dependent upon the induction mechanism and not all cells
responded at the same time resulting in asynchronous apop-
totic cell cultures ~Collins et al., 1997!. In these cases, the
ability to survey large areas rapidly is valuable.
For this review, a subset of the available apoptosis and
other cell death assays was chosen for discussion. Most are
commonly used apoptosis detection techniques and have
been used extensively by the authors. Many of the authors
are studying cell death in developmental systems. Original
findings using these methods are presented in some sections.
TRANSMISSION ELECTRON MICROSCOPY~TEM!
Apoptosis was a term originally used to refer to a cellular
state defined by morphological criteria ~Kerr et al., 1972;
Wyllie et al., 1980!. Categorization of a dying cell as apop-
totic is considered irrefutable if the cells meet ultrastruc-
tural criteria obtained by standard transmission electron
microscopy. The characteristics of an apoptotic cell as as-
sessed by this method are: ~1! intact cellular membranes
even late in the cellular disintegration, ~2! dark and dense
cytoplasm and nucleus, ~3! blebs at the cell surface, ~4! large
clear vacuoles, ~5! disorganized cytoplasmic organization,
and ~6! nuclear fragmentation. The nucleus of an apoptotic
Abbreviations
ACM actin cortical mat
AM acetoxymethyl
Apaf1 apoptosis protease-activating factor-1
ECM extracellular matrix
LSCM laser scanning confocal microscopy
LTR Lysotracker Red
MB methylene blue
MPT mitochondrial permeability transition
NR neutral red
PF paraformaldehyde
PS phosphatidylserine
ROS reactive oxygen species
TB toluidine blue
TEM transmission electron microscopy
TMRM tetramethylrhodamine methylester
TUNEL Terminal dUTP Nick End-Labeling
376 M. Watanabe et al.
cell can also become “marginalized.” In this situation, dark
and dense nuclear material appears to congeal at the nuclear
membrane. Apoptotic cells within a tissue have few if any
cell–cell junctions connecting them to their neighbors and
often appear pulled away from the neighboring cells as they
round up. At late stages, the cells break up into smaller sized
particles. These apoptotic cell fragments or bodies can often
be observed engulfed by surrounding cells such as embry-
onic cardiomyocytes ~Hurle et al., 1978! and adult vascular
smooth muscle cells ~Bennett et al., 1995! or cells special-
ized to be scavengers such as macrophages and Kuppfer cells
of the liver. In some cases, TEM allows simultaneous identi-
fication of cells undergoing apoptosis and the cell type. At
early apoptosis stages the cell type can be identified by the
presence of characteristic features such as striated myo-
fibrils in the case of cardiomyocytes ~Fig. 2! or skeletal
muscle cells ~Borisov and Carlson, 2000!. Immunostaining
for cell-specific antigens will also identify cell types. Unfor-
tunately cells that can be assayed by the classic ultrastruc-
tural criteria are at a late stage in their demise and often lack
the structures or antigens that would identify the cell type.
One of the main disadvantages of TEM is that only a small
region can be observed at one time. This makes surveys and
counts of apoptotic cells by TEM tedious and time-
consuming. Another disadvantage is that preparation of
tissues for TEM requires harsh processing conditions such
as exposure to alcohol, organic solvents, and resins that are
cured at high temperatures. The processing can destroy
antigens or enzymes used to identify specific cells.
STAINED RESIN SECTIONS
Resin-embedded tissues can be sectioned at ;1 mm and
stained with toluidine blue ~TB! or methylene blue ~MB! to
reveal intensely stained apoptotic cells when observed by
standard light microscopy ~Fig. 3!. The tissue and cellular
details are well preserved by this technique. Surveys of large
regions can be done quickly and, once a potentially interest-
ing region of apoptotic cells is identified at the light micro-
scope level, the tissue can be trimmed and sectioned for
more detailed TEM observations. One disadvantage is that
this assay will underestimate the extent of apoptosis occur-
Figure 1. Most of the apoptosis assays detect cellular changes late in apoptosis. The participants in initiation and
execution of apoptosis are shown in white letters on a black background. Assays for earlier events in apoptosis are
presented in the small black squares. The late events in apoptosis are listed in the rectangular box with the
corresponding detection techniques next to them in parentheses. AnxV 5 Annexin V, Apaf1 5 apoptosis protease-
activating factor-1, Death L 5 death ligand, Death R 5 death receptor, dex 5 dexamethazone, MPT 5 mitochondrial
permeability transition, UV 5 ultraviolet light. Other abbreviations are listed on the second page of this article. Diagram
by Colleen Kurzawa.
Apoptosis Assays 377
ring compared to TEM because smaller apoptotic bodies
will not be detected. Another disadvantage is that healthy
cells with large dense intracellular granules can be mistaken
for apoptotic cells or cell fragments. There are also a few
cases where perfectly healthy cells with condensed nuclei
such as lymphocytes or those undergoing mitosis may be
mistaken for apoptotic cells. Another disadvantage similar
to that for TEM is that harsh preparation conditions usually
destroy enzyme activity and antigenic sites thus preventing
postembedding enzyme assays or immunostaining in most
cases.
DNA LADDERING
One of the accepted indicators of apoptosis is the fragmen-
tation of DNA that results in a characteristic “DNA ladder”
where each band in the ladder is separated in size by
approximately 200 bp. The absence of a DNA ladder does
not eliminate the potential that cells are undergoing apop-
tosis because DNA fragmentation occurs late in the apop-
totic process ~Collins et al., 1997!. When cells undergo
apoptosis, endonucleases are activated which cut the DNA
into fragments at sites between the nucleosomes ~for review,
see Zhang and Xu, 2000!. This results in regularly sized
DNA fragments that separate as regularly spaced bands on
an agarose gel. In necrosis, the DNA fragments are ran-
domly cut and dispersed rather than concentrated in
membrane-bound packages. The assay for DNA laddering is
useful for tissues or cell cultures that have high numbers of
apoptotic cells per tissue mass, but not for those with low
numbers.
TUNEL
Labeling DNA fragments is a well accepted and widely used
histological assay for detecting apoptotic cells. This tech-
^
Figure 2. Transmission electron microscopy ~TEM! reveals ultrastructural features of an apoptotic cardiomyocyte in
the embryonic chicken outflow tract myocardium, dark cytoplasm, and clear large vacuoles or vesicles ~arrowheads!.
The cell type was determined by the presence of bundles of myofilaments in the cytoplasm. The diameter of this
apoptotic cell or cell fragment at its widest point is 4 mm. It has been engulfed by a healthy cardiomyocyte.
Figure 3. Methylene blue-stained resin section ~MB! of the embryonic chicken outflow tract. A focus of dying cells was
detected at the distal rim within the outflow tract myocardium in sagittal section. The apoptotic cells and bodies stain a
dark blue ~between black arrows!, but with heterogeneity in size and intensity. The smaller homogeneous blue granules
are found in healthy cells.
Figure 4. Annexin V-stained ~AnxV! cardiomyocyte in the embryonic chicken proximal outflow tract myocardium. The
striated myocyte marker, a monoclonal antibody MF20 that recognizes an isoform of myosin heavy chain, stains the
cytoplasm green ~Alexafluor-488!. The Annexin V-biotin was detected on the plasma membrane of this cell using
avidin-Texas Red. The confocal image was taken with a z-section of 0.8 mm. The cell is approximately 17 mm long.
Figure 5. Comparison of Annexin V ~A! and PhiPhiLux ~B! staining on cultured corneal epithelial from 8-day chicken
embryos. Annexin V ~A! was tagged with Alexafluor 488 ~green! and stains with the characteristic ring pattern of plasma
membrane markers. The same section was costained for actin ~red!. In contrast, the PhiPhiLux ~B! stains the cytoplasm
~green!.
Figure 6. Whole-mount stage 25 quail embryo ~A! in frontal view to show LTR staining ~band of intensely bright red
particles! at the base of the cardiac outflow tract ~oft!. rv 5 right ventricle, lv 5 left ventricle. Hearts are ;1 mm wide at
this stage. Embryonic day 9 mouse ~B! cultured with 250 mM hydroxyurea in vitro for 24 hr ~starting on day 8! and
stained with LTR. LTR staining ~white particles! was increased relative to the control and was detected throughout the
embryo except in the heart ~hrt!. This is a view of the right side of the embryo with the dorsal surface to the left, the
ventral to the right, and the cranial portion is to the top. The heart is 1 mm in diameter. The image is a maximum
projection of 25 individual confocal sections.
Apoptosis Assays 379
nique assays endonuclease cleavage products described in
the last section, the regularly sized DNA fragments that
accumulate and remain concentrated in packages sur-
rounded by intact nuclear membranes. These highly concen-
trated DNA fragments are detected by using terminal
transferase to add labelled nucleotides to the 3' end of DNA
fragments. The procedure is called the Terminal dUTP Nick
End-Labeling ~TUNEL! reaction ~Modak and Bollum, 1972;
Gavrieli et al., 1992!. The dUTP can be labeled with a
variety of probes to permit detection by fluorescence micros-
copy or colorimetric assay. One commercially available kit
uses digoxigenin-labeled nucleotides. The digoxigenin is
detected with antidigoxigenin antibodies tagged with either
a fluorescent marker or peroxidase. The peroxidase label is
visualized by a colorimetric assay such as one using diami-
nobenzidine ~DAB! that results in dark brown precipitates
at the site of positive staining. TUNEL staining typically
requires some form of sample pretreatment, either using
proteinase K or microwaves, to improve sensitivity and the
inclusion of a blocking agent, such as bovine serum, to
reduce background ~Labat-Moleur et al., 1998!. The assays
are available as kits from a number of companies.
One disadvantage of TUNEL is cost. Both the enzyme
and antibody to digoxigenin are expensive. Therefore, this
assay may not be the preferred method for large-scale
analyses requiring the staining of many sections. In addition
to the expense, the TUNEL assay has other limitations. It is
not clear how many DNA breaks are necessary to yield a
positive signal by either TUNEL or the hairpin oligonucleo-
tide method described below ~Schaper et al., 1999!. The
method of fixation and pretreatment can also affect the
detection of DNA strand breaks ~Negoescu et al., 1996!.
Several studies have shown that TUNEL staining cannot
always distinguish apoptotic and necrotic cells ~Grasl-
Kraupp et al., 1995; Schaper et al., 1999! and sometimes this
technique falsely identifies cells in the process of DNA
repair. Additional studies have demonstrated that cells in
the process of active gene transcription can also yield false
positive TUNEL results ~Kockx et al., 1998!. Despite its
well-accepted status, TUNEL is not usually used as the sole
apoptosis assay because of these potential false positives and
is often paired with another assay.
The TUNEL reaction has been used in a number of
studies to evaluate the level of apoptosis during heart devel-
opment and failure. TUNEL staining was used to detect and
quantify the high levels of cardiomyocyte apoptosis associ-
ated with outflow tract shorting during heart development
in chicken embryos ~Watanabe et al., 1998!. In this study,
other assays ~caspase 3 activity, Annexin V! were used in
conjunction with TUNEL to support occurrence of apopto-
sis in that tissue. Two studies reported cardiomyocyte apop-
tosis levels during end stage heart failure in human cardiac
explants ranging from 0.2 to 35 TUNEL-positive nuclei per
100 cardiomyocytes ~Narula et al., 1996; Olivetti et al.,
1997!. The latter number is quite high and has caused
several investigators to question the accuracy of TUNEL
staining ~Schaper et al., 1999!.
Given the uncertainty with which TUNEL staining may
detect nonapoptotic nuclei, an additional method has been
developed that detects double-strand breaks in DNA intro-
duced during apoptosis. Oligonucleotides were synthesized
that were able to discriminate between DNA fragments
containing ends that were blunt or had 3' overhangs. Advan-
tage was taken of the fact that the enzyme~s! that produce
the DNA fragments found in apoptotic cells produce DNA
ends with free 5' phosphate groups capable of ligation to
foreign DNA. Initial experiments used Taq polymerase to
produce labeled ~fluorescent and nonfluorescent!, double-
stranded DNA fragments with a single 3' base overhang and
Pfu polymerase to generate labeled ~fluorescent and nonflu-
orescent!, double-stranded DNA fragments with blunt ends
~Didenko and Hornsby, 1996!. This method was tested on
both paraffin-embedded and frozen tissue samples with no
difference in sensitivity. By comparing the ligation of blunt
and 3' base overhang DNA probes to DNA fragments
generated through apoptotic mechanisms ~thymus treated
with either glucocorticoid or dexamethasone!, necrotic tis-
sue ~Wilms’ tumor!, and tissue with nonapoptotic DNA
damage ~peroxide treated liver, heat-denatured adrenal gland
sections, adrenal gland subjected to autolysis!, Didenko and
Hornsby demonstrated that double-stranded DNA frag-
ments with 3' base overhangs were characteristic of apop-
totic cells while blunt-end DNA fragments, detected to
lesser degrees in tissue with nonapoptotic DNA damage,
were also observed in these cells ~Didenko and Hornsby,
1996!. The inclusion of terminal deoxynucleotidyl transfer-
ase ~TdT! reactions demonstrated that TdT labeled all DNA
with a free 3' end irrespective of the origin of DNA damage.
These studies have now been expanded to include the
design and use of small ~;30 bp! biotin-labeled hairpin
oligonucleotides to detect double-strand DNA breaks
~Didenko et al., 1998!.
Other investigators have used this method to confirm
apoptosis detected with more traditional methods such as
TUNEL. This in situ ligation method was used to show that
TUNEL positive nuclei in cardiac myocytes from hearts in
380 M. Watanabe et al.
the early stages of failure also stained positive for double-
strand DNA breaks ~Ding et al., 2000!. Oligonucleotide
hairpin probes have been used to correlate the activation of
caspase-3, an enzyme that cleaves, among other things,
Bcl-2, destroying its antiapoptotic activity while producing
c-terminal fragments which are proapoptotic ~Wolf and
Green, 1999!, with the presence of DNA damage in a rat
neuronal model of hypoxia-ischemia ~Zhu et al., 2000!. This
study used two other markers for DNA damage, TUNEL
and an antibody directed against single-stranded DNA, and
determined that the hairpin oligonucleotide demonstrated
the greatest degree of colocalization with caspase-3 activity.
In summary, TUNEL is a well-accepted assay to detect
concentrated DNA fragments and can be performed using
commercially available kits. The assay is time-consuming,
expensive, and can lead to false positive results. Some of the
pretreatments ~e.g., proteinase K! eliminate antigenicity and
the integrity of the tissues. As for any apoptosis assay, use of
a second assay based on a different principle is recom-
mended to confirm that what is detected is apoptosis.
ANNEXIN V
Annexin V, a 35–36 kDa protein, binds in the presence of
Ca21 with high affinity to the phosphatidylserine ~PS! resi-
dues exposed to the external plasma membrane surface of
cells dying by apoptosis ~Van den Eijnde et al., 1997a,
1997b; Blankenberg et al., 1999a, 1999b; Blankenberg and
Strauss, 1999!. Healthy cells also have these PS residues, but
manage to keep them all facing the internal or cytoplasmic
surface of the plasma membrane by the ATP-requiring
activity of enzymes called flippases or transmembrane trans-
porters ~for review of these enzymes see Daleke and Lyles,
2000!. When the cell begins to die, it quickly loses its ability
to keep these enzymes active and thus the PS residues
remain on the outside and are detected by Annexin V. The
everted PS serves as a signal that stimulates surrounding
cells to phagocytose the dying cell before the membranes
disintegrate. Annexin V is commercially available labeled
with either fluorescent markers for direct detection or for
indirect labeling using the biotin-avidin systems. The re-
agent must be injected or applied to live cells or tissues at
high concentration for at least 15–30 min before washing
and fixation. This makes it feasible for applying to cells in
culture and young embryos ~e.g., 6–12 somite chick em-
bryos! or injecting into the circulation of older embryos
~e.g., stage 30 chick embryos or 11–13 dpc mouse embryos;
Van den Eijnde et al., 1997a, 1997b; Watanabe et al., 1998!.
It would be very expensive to use for systemic injection into
adult animals even as small as mice. Another disadvantage is
that when injected into animals, Annexin V staining may
vary in intensity and pattern between animals depending on
the efficacy of the injection protocol. As with the other
apoptosis detection systems, it is possible to get positive
staining with Annexin V on certain cells that are not neces-
sarily dying. Subsets of healthy B-lymphocytes and intact
stimulated blood platelets express Annexin V on their sur-
faces ~Tzima et al., 1999; Dillon et al., 2001!.
Annexin V staining has an important advantage for
identifying cell types undergoing apoptosis, as was found in
the analysis of apoptosis in the embryonic myocardium. To
count the number of cardiomyocytes undergoing apoptosis
during development, sections were double-stained for MF20,
an antibody marker for proteins specific to striated myo-
cytes and TUNEL. When a cell was detected that was both
MF20 and TUNEL-positive, it was impossible to determine
whether it was an apoptotic cardiomyocyte containing its
own TUNEL positive nuclear material or a healthy cardi-
omyocyte that had just phagocytosed a TUNEL-positive
apoptotic body. This distinction can be made by using
Annexin V and scanning laser confocal microscopy with an
optical section that is less than 0.2–1 mm thick in the z-axis
~Fig. 4!. Another important advantage that Annexin V has
over TUNEL or vital dyes is that it allows detection of cells
at a slightly earlier phase in the apoptotic pathway ~Van den
Eijnde et al., 1997b! when antigens required for cell identi-
fication may still be intact.
CASPASE-3 ACTIVITY ASSAYS
Caspase-3 ~previously known as CPP32, YAMA, apopain! is
a cysteine protease activated in the terminal apoptosis cas-
cade. It is sequestered in the cytoplasm as a zymogen in its
inactive form and activated when cleaved by other caspases.
Its preferred sequence for protein cleavage is DEVD
~aspartate-glutamate-valine-aspartate! with an absolute re-
quirement for the terminal aspartate ~for review, see Nich-
olson and Thornberry, 1997!. The peptide DEVD-AFC,
when cleaved by Caspase-3, releases AFC, a fluorescent tag
that may be monitored in a fluorometer with the appropri-
ate excitation and emission settings. This method requires
homogenization of the cells of tissues to release the en-
Apoptosis Assays 381
zymes into solution. This step obviously destroys the integ-
rity of the tissue being assayed and precludes localizing the
event within the tissue or determining the cell type under-
going apoptosis. There is also a limitation in the size of the
tissues that can be assayed. For embryonic tissues, it is often
necessary to pool tissue dissections to get enough material
to detect the Caspase-3 activity. The advantage of this
method is that it allows rapid and consistent quantification
and is suitable for a time-course analysis for cells in culture.
It also works for complex tissues where several cell types are
present, but only one type undergoes changes in the level of
apoptosis. In the case of developing heart tissue in which
the epicardium, endocardium, and myocardium are all un-
dergoing apoptosis, the Caspase-3 assay allowed analysis of
the myocardial apoptosis only because it dominated at the
peak of apoptosis while the other tissues had fairly consis-
tent, low levels of apoptosis as assessed by TUNEL ~Wa-
tanabe et al., 1998!. We confirmed the dynamic changes in
the level of apoptosis in the myocardium by using the
TUNEL and Annexin V techniques in tissue sections taken
at the same stages.
The cell permeable peptide PhiPhiLux ~fluorescent-
fluorescent light; OncoImmunin, Inc.! was made to visual-
ize caspase-3 activity in living cells. This class of fluorogenic
protease substrates was used to determine if the corneal
epithelial sheets contained active caspase-3 and to compare
to Annexin V staining ~Fig. 5!. The PhiPhiLux molecule
contains the caspase-3-recognition sequence DEVD in a
bifluorophore-derivitized peptide that mimics the struc-
tural loop conformation present in the native protease
cleavage sites of globular proteins. Therefore, the com-
pound is not fluorescent unless it is cleaved by endogenous
caspase-3 ~Packard et al., 1997!. Corneal epithelial tissues
isolated without basal lamina ~2BL! respond to ECM using
an actin-dependent mechanism. The basal cell surface flat-
tens and the disrupted actin cortical mat ~ACM! reorganizes
in the presence of laminin, fibronectin, or collagen ~Sugrue
and Hay, 1981, 1986; Svoboda and Hay, 1987; Svoboda,
1992; Khoory et al., 1993! with distinct configurations in
the presence of different ECM molecules ~Svoboda et al.,
1999!. The loss of integrin-mediated cell–matrix attach-
ment induces apoptosis in many anchorage dependent cell
types. The corneal epithelial model used in this study main-
tains cell–cell attachments while separating the cell–matrix
attachment complex. A study was designed to determine if
disrupting the signal transduction pathways involved in
integrin-mediated actin reorganization increases apoptosis.
Briefly, corneal epithelia were isolated from 8-day chicken
embryos without the basal lamina and incubated overnight
with either control media or media containing 100 mg/ml
collagen I or 50 mg/ml fibronectin in the presence or ab-
sence of an inhibitor that blocks actin reorganization. In
the last hour of incubation, PhiPhiLux was added to the
media of the live tissues. Alternatively, tissues were incu-
bated in labeled Annexin V for 15 minutes. The tissues
were rinsed, fixed, and stained with Texas Red phalloidin.
Whole tissues were morphologically analyzed using a Leica
TSP SP2 confocal microscope for actin, Annexin V, and
FITC-PhiPhiLux ~Fig. 5!. Control tissues incubated with
or without fibronectin or collagen had low levels of PhiPhi-
Lux or Annexin V. In contrast, increasing doses of the
kinase inhibitor increased the staining, indicating that the
tissues were positive for Caspase-3 and Annexin V. It was
concluded that the Caspase-3 substrate and Annexin V
binding were more sensitive than other apoptosis detection
methods. In addition, incubating the cells with either sub-
strate did not disrupt staining for other proteins, such as
actin.
The advantages of these substances are that they can be
used on live cells and the PhiPhiLux penetrates cell mem-
branes and offers the caspase-3 a three-dimensional target.
In addition, both compounds can be visualized with confo-
cal microscopy and do not fade with laser excitation. The
disadvantages of PhiPhiLux are similar to that for Annexin
V. It is expensive and needs to be used at high concentra-
tions. Also, it may not penetrate into dense tissues or whole
embryos effectively.
VITAL DYES AND LYSOTRACKER RED
Apoptosis has been previously visualized in whole embryos
using the vital dyes, acridine orange ~AO!, Nile blue sulfate
~NBS!, or neutral red ~NR!. These dyes are acidophilic and
are concentrated in areas of high lysosomal and phagocyto-
sis activity. They have been used for a number of years even
before the term apoptosis was coined. These dyes would not
distinguish between lysosomes degrading apoptosis-
associated debris and other debris such as microorganisms.
For this reason, their use as apoptosis markers would have
to be validated using other apoptosis assays.
Acridine Orange is a cationic dye that binds DNA and
RNA by intercalating or electrostatic interactions. It has
green fluorescence ~emission maximum of 525 nm! when
bound to DNA and a red fluorescence ~emission shifted to
382 M. Watanabe et al.
650 nm! when bound to RNA. Condensed chromatin can-
not be stained by AO. Under flow cytometry, apoptotic cells
exhibit lower levels of green fluorescence and higher levels
of red fluorescence. It can also be used on whole tissues and
embryos ~Buckiova et al., 1998; Farlie et al., 1999!. The
disadvantages are that it can be easily photobleached during
routine observation, it is a mutagen, and it is difficult to
maintain AO fluorescence during processing for analysis in
sections.
In developing embryos, Nile Blue Sulfate stains the
lysosomes and acidic cellular compartments that correlate
to regions where the apoptotic bodies are located ~Saunders
and Gasseling, 1962; Saunders, 1966; Menkes et al., 1979;
Hurle, 1988; Lumsden et al., 1991; Kotch et al., 1992; Kotch
and Sulik, 1992; Alles and Sulik, 1993; Gao et al., 1994; Allen
et al., 1997; Zakeri, 1998!. AO and NB colocalized in Dro-
sophila embryos. The distribution of these dyes closely
resembled that of pyknotic figures derived in plastic sec-
tions with TB staining ~Abrams et al., 1993!. From a sequen-
tial analysis of the same embryo, it was concluded that NBS
and AO staining in vivo was equivalent to TB staining after
fixation, and these dyes were indeed staining the apoptotic
cells/nuclei. It was also shown that AO and NBS were
detecting both free and phagocytosed cell corpses. NBS has
been shown by numerous investigators to be a suitable stain
to visualize apoptosis in the embryo or fetal limbs, as it
appears to stain the same specific regions that have been
designated as apoptotic by some other well-characterized
apoptotic assays such as TUNEL and the Annexin V assay
~Knudsen, 1992; Kotch and Sulik, 1992; Alles and Sulik,
1993; Zakeri et al., 1994; Van den Eijnde et al., 1997b;
Nakamura et al., 2000!.
Although NBS is valuable for quick, inexpensive analy-
sis of large numbers of specimens, the use of this vital stain
has limitations due to restricted dye penetration and poor
dye retention. It is also difficult to see the dye through
thicker tissue. NBS works well in whole mounts of small
embryos ~Buckiova et al., 1998; Farlie et al., 1999! or tissues,
but the dye staining is lost while preparing tissues for
sectioning. NBS and NR dyes can also label cells with
condensed granules that are not undergoing cell death.
LysoTracker Red ~LTR; Molecular Probes! acts in a
similar way to NBS by accumulating in the acidic intracellu-
lar compartments and regions where there is a high amount
of phagolysosomal activity resulting from the engulfment of
apoptotic bodies by adjacent cells ~Zucker et al., 1998, 1999,
2000a, 2000b!. LTR is a red fluorescent dye that excites with
a maximum at 568 nm and can be detected with standard
excitation and emission filters used to detect other red
fluorescent dyes such as rhodamine and Texas Red. It has
the added advantage of being an aldehyde fixable probe that
penetrates easily into tissues. The dye still maintains its
fluorescent characteristics in sample preparation procedures
that use 100% MEOH for dehydration and organic com-
pounds benzyl alcohol and benzyl benzoate ~BABB! for
clearing. These characteristics of LTR make it suitable to be
used with laser scanning confocal microscopy ~LSCM! to
provide three-dimensional imaging of cell death in tissue
that is as thick as 0.5 mm.
It has been previously shown that LTR has a similar
staining pattern as the other acidophilic dyes used in embry-
ology to stain apoptotic cells in the embryo and the limb
~Menkes et al., 1979; Kotch and Sulik, 1992; Zakeri et al.,
1994; Zucker et al., 1998, 1999; Nakamura et al., 2000!.
Whereas NBS and LTR were used for the morphological
identification of apoptotic bodies, TUNEL provided a
biochemical-based detection of apoptosis ~Gard, 1993; Allen
et al., 1997!. These data on lysomorphic dyes and Annexin
V/TUNEL biochemical data show that both morphological
and biochemical approaches visualize the induction of apop-
tosis. LTR staining ~Zucker et al., 1998, 1999, 2000a, 2000b!
and cell death labeling using other lysosomotropic dyes
~NBS, AO, and NR! were compared to other apoptosis-
specific biochemical assays ~TUNEL and Annexin V! to
show equivalency of cell death patterns with all the different
probes suggesting that they are staining the same regions. It
thus appears that LTR may directly correspond to biochem-
ical events represented by DNA strand breaks ~TUNEL! and
late stage Annexin V uptake in dead cells and may be
considered to be an indicator of apoptosis in tissue. This
LTR method has allowed visualization of apoptosis in whole
embryos, fetal limbs, and neonatal tissue using LSCM. LTR
staining in whole mounts of avian and murine embryonic
hearts ~Fig. 6A,B! has been used to identify in three dimen-
sions where and when apoptosis normally occurs and to
assess the effects of various reagents such as ETOH and
hydroxyurea ~Zucker et al., 1999! on apoptosis.
Technical difficulties associated with using LTR have to
be overcome if it is to be used as an accurate indicator of
apoptosis. These include the staining conditions of the dye.
This should be done in a tissue culture medium at 378C that
contains serum to protect and maintain the viability of the
tissue. The penetration of the dye into the tissue is crucial to
visualizing the regions of apoptosis in three dimensions.
Fixation should be done with an aldehyde ~4% paraformal-
dehyde @PF# or 1% glutaraldehyde! and the temperature
Apoptosis Assays 383
should be regulated to minimize fixation artifacts while
maximizing the sample fixation. PF was used at cold tem-
peratures and glutaraldehyde at all temperatures. Glutaral-
dehyde has the advantage of promoting excellent fixation,
but its major disadvantage was that it increased nonspecific
autofluorescence when using 488-laser excitation. By using
the 568 lasers to excite LTR, the autofluorescence was avoided.
LTR-stained intact embryos and hearts have been viewed
without further steps to visualize apoptosis close to the
surface of the samples ~within 300 mm from the surface!.
However, the clearing procedure is essential to visualize LTR
staining within thick tissue ~Klymkowsky and Hanken, 1991;
Gard, 1993; Zucker et al., 1998!. Extreme care must be taken
to remove all water from the samples and it is useful to
open fresh 100% MEOH in the final dehydration step. It is
also important to slowly change the percentages of MEOH
in the dehydration steps and BABB in the clearing steps to
minimize shrinking. BABB is damaging to plastic and glass
objectives; thus extreme care should be used to maintain the
samples in their holders and to prevent BABB from leaking
onto the surface of the slide. The use of air lenses is
recommended when viewing these samples so as to mini-
mize the risk of any contamination and potential damage of
expensive lenses with BABB. Finally it should be empha-
sized that LTR intensely stains acidic structures that may
not be associated with apoptosis as indicated by the distinct
nucleolar RNA staining in the normal oocyte ~Zucker et al.,
2000b!.
After the LTR-stained specimens are cleared in BABB,
the refractive index of the specimen becomes similar to the
surrounding BABB medium. Thus the specimen becomes
more transparent as there is a reduction of light scattering
and absorption effects. The result is that the laser can
penetrate the tissue with increased effectiveness. The whole
embryo can be observed with this approach. Individual
digital images of the embryo or other tissue are first ac-
quired by LSCM and then compiled into a whole three-
dimensional structure of the initial organism or tissue using
imaging software. The technique allows for the penetration
of light for over 0.5 mm with low power objectives and can
be increased using a two-photon laser confocal scanning
microscope. The LTR method of apoptosis detection does
provide an invaluable three-dimensional visualization of
embryonic apoptosis. This technique does have limitations,
which include a lengthy sample preparation using organic
compounds and the use of costly confocal equipment. An-
other limitation in using LTR is demonstrated by the obser-
vation that it can stain nonapoptotic regions in cells/tissues
that are acidic such as the nucleolus of an oocyte ~Zucker
et al., 2000b!.
Flow cytometry has been used to try to quantify apop-
tosis on a population of cells using a number of different
methods ~Darzynkiewicz et al., 1997!. It would be highly
desirable to make a similar type of assessment in tissues and
embryos. Previous attempts have been made to quantify
whole embryo cell death by detecting fluorescence intensi-
ties derived from whole embryos to provide a semiquantita-
tive assessment of apoptosis in teratogen-exposed embryos
~Gao et al., 1994; Lee et al., 1996; Ambroso et al., 1998!.
Preliminary data suggests that if conditions in the LSCM
are kept constant, it may be possible to evaluate apoptosis in
three dimensions with a LSCM using LTR fluorescent dye as
an indicator ~Zucker and Price, 1999!. There are many
variables that affect the analysis. Ideally it would be useful
to establish a threshold of pixel intensity, above which the
apoptosis index would occur. This apoptotic index will be
complex and subject to both biological errors of interpreta-
tion and technical errors in the acquisition of this data
using low power objectives. Due to the unpredictable nature
of apoptotic body formation and their subsequent engulf-
ment by neighboring cells, efforts to quantify apoptosis as a
function of fluorescence intensity can only be an approxi-
mation. However dose-dependent effects on fetal limb tis-
sue have been observed after treatment in vivo with the
chemotherapeutic drug 5-fluorouracil ~Lau et al., 2001!.
In summary, LTR has the advantages of being an inex-
pensive aldehyde fixable probe that penetrates easily into
tissues while being highly fluorescent even after harsh treat-
ments such as incubation in 100% MEOH ~dehydration! or
100% BABB ~clearing!. As a fluorescent agent, it can be used
with LSCM for double or triple labeling using other assays.
The properties of LTR allow analysis of whole-mount or-
gans, tissues, and embryos and reduce the need for sections
and three-dimensional reconstruction. The fluorescence is
very bright and resistant to quenching. This assay would not
work for cells that are known to have large acidic compart-
ments in their normal state such as macrophages or oocytes.
MITOCHONDRIAL ASSAYS
Mitochondria play an important role in apoptotic and
necrotic cell death. Depending on the stimulus, a variety of
mitochondrial dysfunctions can trigger the onset of cell
death. Assessment of mitochondrial dysfunction in living
384 M. Watanabe et al.
cells in situ is important in understanding the sequence of
molecular and subcellular events producing cell injury and
death. LSCM creates submicron thin optical slices through
living cells and tissues and allows several mitochondrial
events to be monitored simultaneously in intact single cells
over time.
Several mitochondrial parameters, such as mitochon-
drial redox status, Ca21 increase, reactive oxygen species
~ROS!, the mitochondrial permeability transition, and mito-
chondrial depolarization can be monitored with LSCM in
single living cells. These events have been shown to occur in
apoptotic as well as necrotic processes. Oxidative stress can
induce oxidation of mitochondrial pyridine nucleotides that
can be visualized directly by ultraviolet LSCM of NAD~P!H
autofluorescence.
An increase of mitochondrial Ca21 can be measured by
the Ca21-indicating fluorophore, Rhod-2 ~Byrne et al., 1999!.
Rhod-2 AM has a net positive charge and is drawn electro-
phoretically into mitochondria where it is hydrolyzed to its
free calcium indicating form. Unlike other calcium indica-
tors, such as Fura-2 and Indo-1, Rhod-2 is not a ratiometric
probe and therefore quantitation of Ca21 concentrations
within cells is difficult. Rather, Rhod-2 monitors relative
changes in Ca21 concentrations.
A number of fluorophores can be used to measure
mitochondrial ROS generation. Nonfluorescent 2 ',7 '-
dichlorofluorescein is converted to highly fluorescent 2',7'-
dichlorofluorescein by hydroperoxides ~Nieminen et al.,
1997!. The probe that can be used to detect mitochondrial
superoxides is dihydroethidium. Dihydroethidium is oxi-
dized by superoxides to fluorescent ethidium. The oxidized
form of this probe, ethidium, binds to nucleic acids, thus
making the nuclei brightly fluorescent.
In isolated mitochondria, a wide variety of oxidant
chemicals induce increased nonspecific permeability of the
mitochondrial inner membrane to ions and solutes of mo-
lecular weight # 1500 Da. This mitochondrial permeability
transition ~MPT! causes mitochondrial swelling, membrane
depolarization, and uncoupling of oxidative phosphoryla-
tion. Although the MPT was originally observed during
necrotic cell death, it also may explain the release of mito-
chondrial pro-apoptotic proteins, such as cytochrome c and
apoptosis-inducing factor. A technique to monitor the MPT
in intact cells has been developed. When cultured hepato-
cytes are incubated at 378C with the acetoxymethyl ~AM!
ester of calcein, the neutral ester crosses the plasma mem-
brane. Cytosolic esterases then hydrolyze calcein-AM to the
free acid form whose ionized carboxyl groups trap and
retain the fluorophore inside the cytosolic compartment.
Calcein displays bright green fluorescence that is indepen-
dent of changes in pH and Ca21. After calcein loading of
hepatocytes at 378C, its diffuse fluorescence in confocal
images shows its distribution within the cytosolic compart-
ment. Within this diffuse fluorescence are many individual
dark voids of about a micron in diameter. To identify these
voids in the calcein fluorescence, cells can be loaded with
tetramethylrhodamine methylester ~TMRM!, a red fluoresc-
ing cationic dye that accumulates electrophoretically in
mitochondria in response to their negative membrane po-
tential. Fluorescence of the two probes is then imaged
simultaneously using LSCM. Virtually every dark round
void in the green calcein image is a TMRM-labeled mito-
chondrion in the red image. Thus, the dark voids in the
calcein images are individual mitochondria. The dark voids
exist for the reason that the mitochondrial inner membrane
is highly impermeable to calcein. When the mitochondrial
membrane degrades, or MPT occurs, individual mitochon-
dria fill up with calcein, resulting in an image with diffuse
calcein fluorescence. This event was accompanied by mito-
chondrial depolarization, as shown by loss of mitochondrial
TMRM fluorescence ~Nieminen et al., 1995!.
Aside from the morphological changes associated with
the nucleus and plasma membrane of cells undergoing
apoptosis, other biochemical changes inside the cell may
have an equally important role in the propagation of apop-
totic signals. One such change involves the release of cyto-
chrome c from mitochondria. Although several mechanisms
for cytochrome c release have been proposed, including
mitochondrial depolarization, outer mitochondrial mem-
brane rupture and opening of permeability transition
pores ~Haunstetter and Izumo, 1998; Heiskanen et al., 1999;
Saraste and Pulkki, 2000!, it remains unclear exactly
how cytochrome c escapes the mitochondria. The function
of cytochrome c outside of the mitochondria is very clear;
cytochrome c interacts with Apaf-1 and caspase-9 to acti-
vate caspase-3 ~Haunstetter and Izumo, 1998!. Therefore,
localization of cytochrome c may provide an early indica-
tion of apoptosis; however, the amount of cytochrome c
necessary in the cytoplasm to trigger apoptosis remains
unknown ~Willingham, 1999!.
The distribution of cytochrome c has been examined in
apoptotic cells using both fluorescence and electron micros-
copy methods ~Heiskanen et al., 1999!. Green fluorescent
proteins ~GFP! can be utilized to detect mitochondrial
events during apoptosis in living cells by LSCM. Recently, a
method to visualize simultaneously cytochrome c release
Apoptosis Assays 385
and mitochondrial depolarization in intact cells has been
developed. Cells transfected with a cytochrome c-GFP fu-
sion construct were loaded with TMRM, a mitochondrial
membrane potential sensitive probe. The green and red
fluorescence of cytochrome c-GFP and TMRM were imaged
by confocal microscopy ~Fig. 7!. The results show that
mitochondrial depolarization accompanied cytochrome c
release during apoptosis. Moreover, individual mitochon-
dria depolarized and released their cytochrome c asynchro-
nously ~Heiskanen et al., 1999!. Besides cytochrome c, other
apoptotic or antiapoptotic proteins, such as Bax, Bid, and
Bcl-2, can be visualized as their fluorescent protein deriva-
tives with confocal microscopy. Using fluorescent-protein-
tagged fusion proteins, one needs to take into consideration
that the fluorescent protein tag may alter the interaction of
the native protein of interest with other proteins. Therefore,
it is advisable to confirm the results by immunocytochemis-
try or immunoprecipitation, if possible.
A fluorescently labeled anticytochrome c antibody was
used to monitor photoirradiation-induced depolarization
of the mitochondrial inner membrane by chloromethyl-X-
rosamine that ultimately resulted in apoptosis ~Minami-
kawa et al., 1999!. These studies showed a dramatic
redistribution of cytochrome c from the mitochondria into
the cytoplasm after photoirradiation. Ultrastructural local-
ization of cytochrome c was examined in tissue sections
Figure 7. Cytochrome c-GFP ~Green Fluorescent Protein! was maintained in the mitochondria before apoptosis and
stained green particles within the cytoplasm. Once it was released during apoptosis, the green particles disappeared and
the cytoplasm became diffusely stained. Cytochrome c-GFP transfected breast cancer cells were loaded with a
mitochondrial membrane potential indicating probe tetramethylrhodamine methyl ester ~TMRM!. Images of green
cytochrome c-GFP fluorescence and red TMRM fluorescence were collected using LSCM. After collecting basal images
~top row!, 1 mM staurosporine was added to induce apoptosis ~bottom row!. In the baseline image, the punctate
fluorescence of green cytochrome c-GFP colocalized with the red TMRM fluorescence ~overlay!. After an 8-hr exposure
to staurosporine ~bottom row!, TMRM and cytochrome c-GFP redistributed from mitochondria to the cytosol as
indicated by a diffuse TMRM and cytochrome c-GFP fluorescence pattern. This indicated mitochondrial depolarization
and cytochrome c release. Bar 5 10 mm.
386 M. Watanabe et al.
Table 1. Pros and Cons of Apoptosis Assays
Assay Pros Cons Recommended applications
TEM • Definitive
• Ultrastructural characteristics of
apoptotic cells can be observed
• Time-consuming
• Assays small regions at a time
• Harsh processing conditions
can reduce antigenicity
Sections of regions with lots of
apoptosis or after localization of
cells with thick stained resin
sections
Stained resin sections • Can survey large regions and
sections for TEM
• Detailed tissue analysis possible
• Difficult to maintain antigenicity
for immunohistological or
enzyme assays
Sections with low or high levels
of apoptosis
Caspase-3 activity • Kits available
• Quantitative
• Cannot identify specific cell or
tissue where the apoptosis is
occurring
• Need substantial amounts
of tissue with high levels of
apoptosis
Cells and tissues in culture and
tissue extracts
Acridine Orange • Fast
• Inexpensive
• Fluorescent
• Penetrates tissues
• Toxic
• Mutagenic
• Induces phototoxicity
• Quenches rapidly under standard
conditions
Whole mounts of small embryos
~zebrafish and chick! and tissues
NBS and NR • Fast
• Inexpensive
• Does not penetrate thick tissues
• Lost during preparation for
sectioning
• Hard to visualize in thick or
opaque tissues
Whole mounts of transparent
embryos, organs, tissues
TUNEL • Kits are available
• Well-accepted assay
• Can be used in whole mounts
of thin tissues
• Expensive
• Time-consuming
• Often requires harsh pretreatment
~microwaving or proteinase K!
• False positives possible
Histological sections:
formaldehyde fixed and paraffin
embedded embryos and tissues
or frozen-sectioned and
postfixed samples.
Annexin V • Detects apoptotic cells earlier
than TUNEL
• Allows double and triple
labeling
• Expensive for whole animal
studies
• Variable success with animal
injections
Cell culture and cell sorting,
small embryos
LTR ~Lysotracker Red! • Inexpensive
• Fast
• Penetrates thick tissues
• Stable during fixation and
dehydration
• Resistant to quenching
• Mild staining conditions allow
retention of antigenicity
• Potential false positives for cells
with acidic compartments such
as macrophages and oocytes
• Need to permeabilize to see
through thick tissues in whole
mounts
Whole mounts of tissues, organs,
or embryos and cell culture
PhiPhiLux • Specific to caspase-3/apoptosis
• Assays living cells
• Limited permeability Cell or tissue culture
Mitochondrial assays • Assayed in living cells • Mitochondrial events occur in
apoptosis and necrosis
Cells or tissue culture
Cytochrome C release • Assayed in living and fixed cells Cells or cell culture but has been
used in tissues
Apoptosis Assays 387
from ischemic cardiomyopathic hearts using an anticyto-
chrome c antibody followed by a gold-conjugated second-
ary antibody ~Narula et al., 1999!. In normal heart tissue,
cytochrome c localization was restricted to the mitochon-
dria. In contrast, little cytochrome c was detected in the
mitochondria and substantial staining of cytochrome c was
observed in the Z-bands and intercalated discs of cardiomyo-
pathic hearts.
In summary, a variety of mitochondrial events can be
monitored in living cells over time using multiparameter
LSCM. This technique allows us to assess which mitochon-
drial events are critical for progression of cell injury during
any given pathological condition. The possible limitation of
the technique is laser-light-induced photodamage to living
specimens. However, this can be avoided by attenuation of
the laser power to the minimum possible.
SUMMARY AND CONCLUSION
A wide menu of classic and contemporary techniques cur-
rently available to analyze cell death allows investigators to
select those best suited to specific applications ~Table 1!. No
matter how appropriate and well accepted the assay, it is
recommended that a second assay using a different princi-
ple be used to confirm the detection of apoptosis. More
accurate and precise interpretations of the results of these
assays will become possible as progress continues to be
made in understanding the mechanisms of cell death. The
rapid progress and continued interest in the study of cell
death could spur the development of new protocols or the
modification of old protocols to overcome some of the
current disadvantages with the cell death assays.
ACKNOWLEDGMENTS
The research described in this article has been reviewed and
approved for publication as an EPA document. Approval
does not necessarily signify that the contents reflects the
views and policies of the Agency, nor does mention of trade
names or commercial products constitute endorsement or
recommendation for use. The work was supported in part
by NSF #0074882 ~MW!, NIH HL65314 ~SF!, NIH NS39469
~ALN!, AHA ~SF, MW, FR!.
REFERENCES
Abrams, J.M., White, K., Fessler, L.I. & Steller, H. ~1993!.
Programmed death during drosophila embryogenesis. Develop-
ment 117, 29–43.
Allen, R.T., Hunter, W.J., III & Agrawal, D.K. ~1997!. Morpho-
logical and biochemical characterization and analysis of apop-
tosis. J Pharmacol Toxicol Methods 37, 215–228.
Alles, A.J. & Sulik, K.K. ~1993!. A review of caudal dysgenesis
and its pathogenesis as illustrated in an animal model. Birth
Defects 29, 83–102.
Ambroso, J.L., Stedman, D.B., Elswick, B.A. & Welsch, F. ~1998!.
Characterization of cell death induced by 2-methoxyethanol in
CD-1 mouse embryos on gestation day. Teratology 58, 231–240.
Anversa, P., Olivetti, G., Leri, A., Liu, Y. & Kajstura J. ~1997!.
Myocyte cell death and ventricular remodeling. Curr Opin
Nephrol Hyperten 6, 169–176.
Ashkenazi, A. & Dixit, V.M. ~1999!. Apoptosis control by death
and decoy receptors. Curr Opin Cell Biol 11, 255–260.
Bennett, M.R., Gibson, D.F., Schwartz, S.M. & Tait, J.F. ~1995!.
Binding and phagocytosis of apoptotic vascular smooth muscle
cells is mediated in part by exposure of phosphatidylserine.
Circ Res 77, 1136–1142.
Blankenberg, F., Ohtsuki, K. & Strauss, H.W. ~1999a!. Dying a
thousand deaths. Radionuclide imaging of apoptosis. Q J Nucl
Med 43, 170–176.
Blankenberg, F. & Strauss, H.W. (1999!. Non-invasive diagnosis
of acute heart- or lung-transplant rejection using radiolabeled
annexin V. Pediatr Radiol 29, 299–305.
Blankenberg, F., Tait, J.F. & Strauss, H.W. ~2000!. Apoptotic
cell death: Its implications for imaging in the next millennium.
Eur J Nucl Med 27, 359–367.
Blankenberg, F.G., Katsikis, P.D., Tait, J.F., Davis, R.E., Nau-
movski, L., Kopiwoda, S., Abrams, M.J. & Strauss, H.W.
~1999b!. Imaging of Apoptosis ~programmed cell death! with
99mTc annexin V. J Nucl Med 40, 184–191.
Borisov, A.B. & Carlson, B.M. ~2000!. Cell death in denervated
skeletal muscle is distinct from classical apoptosis. Anat Rec
258, 305–318.
Bowen-Pope, D.F. & Schaub, F.J. ~2001!. Apoptosis of smooth
muscle cells is not silent: Fas/FADD initiates a program of
inflammatory gene expression. Trends Cardiovasc Med 11, 42–45.
Buckiova, D., Kubínová, L., Soukup, A., Jelinek, R. & Brown,
N.A. ~1998!. Hyperthermia in the chick embryo: HSP and
possible mechanisms of developmental defects. Int J Dev Biol
42, 737–740.
Bursch, W., Kleine, L. & Tenniswood, M. ~1990a!. The biochem-
istry of cell death by apoptosis. Biochem Cell Biol 88, 1071–1074.
Bursch, W., Paffe, S., Putz, B., Barthel, G. & Schulte-
Hermann, R. ~1990b!. Determination of the length of the
388 M. Watanabe et al.
histological stages of apoptosis in normal liver and in altered
hepatic foci in rats. Carcinogenesis 11, 847–853.
Byrne, A.M., Lemasters, J.J. & Nieminen, A.-L. ~1999!. Contribu-
tion of increased mitochondrial free Ca to the tert-
butylhydroperoxide-induced mitochondrial permeability
transition in rat hepatocytes. Hepatology 29, 1523–1531.
Collins, J.A., Schandl, C.A., Young, K.K., Vesely, J. & Willing-
ham, M.C. ~1997!. Major DNA fragmentation is a late event in
apoptosis. J Histochem Cytochem 45, 923–934.
Daleke, D.L. & Lyles, J.V. ~2000!. Identification and purification
of aminophospholipid flippases. Biochim Biophys Acta 1486,
108–127.
Darzynkiewicz, Z., Jaun, G., Xun, L., Gorczyca, W., Mura-
kami, T. & Traganos, F. ~1997!. Cytometry and cell necrobiol-
ogy: Analysis of apoptosis and accidental cell death necrosis.
Cytometry 27, 1–20.
De Laurenzi, V. & Melino, G. ~2000!. Apoptosis. The little devil
of death. Nature 406, 135–136.
Didenko, V.V. & Hornsby, P.J. ~1996!. Presence of double-strand
breaks with single-base 3' overhangs in cells undergoing apop-
tosis but not necrosis. J Cell Biol 135, 1369–1376.
Didenko, V.V., Tunstead, J.R. & Hornsby, P.J. ~1998!. Biotin-
labeled hairpin oligonucleotides: Probes to detect double-strand
breaks in DNA in apoptotic cells. Am J Pathol 152, 897–902.
Dillon, S.R., Constantinescu, A. & Schlissel, M.S. ~2001!.
Annexin V binds to positively selected B cells ~2001!. J Immunol
166, 58–71.
Ding, B., Price, R.L., Goldsmith, E.C., Borg, T.K., Yan, X.,
Douglas, P.S., Weinberg, E.O., Bartunek, J., Theilen, T.,
Didenko, V.V. & Lorell, B.H. ~2000!. Left ventricular hyper-
trophy in ascending aortic stenosis mice: Anoikis and the
progression to early failure. Circulation 101, 2854–2862.
Farlie, P.G., Kerr, R., Thomas, P., Symes, T., Minichiello, J.,
Hearn, C.J. & Newgreen, D. ~1999!. A paraxial exclusion zone
creates patterned cranial neural crest cell outgrowth adjacent to
rhombomeres 3 and 5. Dev Biol 213, 70–84.
Gao, X., Blackburn, M.R. & Knudsen, T.B. ~1994!. Activation of
apoptosis in early mouse embryos by 2'-deoxyadenosine expo-
sure. Teratology 49, 1–12.
Gard, D.L. ~1993!. Confocal immunofluorescence microscopy of
microtubules in amphibian oocytes and eggs. Methods Cell Biol
38, 231–264.
Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. ~1992!. Identifica-
tion of programmed cell death in situ via specific labeling of
nuclear DNA fragmentation. J Cell Biol 119, 493–501.
Grasl-Kraupp, B., Ruttkay-Nedecky, B., Koudelka, H.,
Bukowska, K., Bursch, W. & Schulte-Hermann, R. ~1995!.
In situ detection of fragmented DNA ~TUNEL assay! fails to
discriminate among apoptosis, necrosis, and autolytic cell death:
A cautionary note. Hepatology 21, 1465–1468.
Haunstetter, A. & Izumo, S. ~1998!. Apoptosis: Basic mecha-
nisms and implications for cardiovascular disease. Circ Res 82,
1111–1129.
Heiskanen, K.M., Bhat, M.B., Wang, H.W., Ma, J. & Nieminen,
A.-L. ~1999!. Mitochondrial depolarization accompanies cyto-
chrome c release during apoptosis in PC6 cells. J Cell Biol 274,
5654–5658.
Hurle, J.M. ~1988!. Cell death in developing systems. Meth Achiev
Exp Path 13, 55–86.
Hurle, J.M., Lafarga, M. & Ojeda, J.L. ~1978!. In vivo phagocy-
tosis by developing myocardial cells: An ultrastructural study.
J Cell Sci 33, 363–369.
Kerr, J.F.R., Wyllie, A.H. & Currie, A.R. ~1972!. Apoptosis: A
basic biological phenomenon with wide-ranging implications
in tissue kinetics. Br J Cancer 26, 239–257.
Khoory, W., Wu, E. & Svoboda, K.K. ~1993!. Intracellular relation-
ship between actin and alpha-actinin in a whole corneal epithe-
lial tissue. J Cell Sci 106, 703–717.
Klymkowsky, M.W. & Hanken, J. ~1991!. Whole mount staining
of Xenopus and other vertebrates. Methods Cell Biol 36, 419–441.
Knudsen, T.B. ~1992!. In vitro approaches to the study of embry-
onic cell death in developmental toxicity. In In Vitro Methods in
Developmental Toxicity: Use in Defining Mechanisms and Risk
Parameters, Kimmels, G.L. & Kochhar, D.M. ~Eds.!, pp. 129–
142. Boca Raton, FL: CRC Press.
Kockx, M.M., Muhring, J., Knaapen, M.W. & de Meyer, G.R.
~1998!. RNA synthesis and splicing interferes with DNA in situ
end labeling techniques used to detect apoptosis. Am J Pathol
152, 885–888.
Kotch, L.E., Dehart, D.B., Alles, A.J., Chernoff, N. & Sulik,
K.K. ~1992a!. Pathogenesis of ethanol induced limb reduction
defects in mice. Teratology 46, 323–332.
Kotch, L.E. & Sulik, K.K. ~1992b!. Patterns of ethanol-induced
cell death in the developing nervous system of mice; neural
fold states through the time of anterior neural tube closure. Int
J Dev Neurosci 10, 273–279.
Labat-Moleur, F., Guillermet, C., Lorimier, P., Robert, C.,
Lantuejoul, S., Brambilla, E. & Negoescu, A. ~1998!. TUNEL
apoptotic cell detection in tissue sections: Critical evaluation
and improvement. J Histochem Cytochem 46, 327–334.
Latour, I., Leunda-Casi, A., Denef, J.F. & Buc Calderon, P.
~2000!. Activation of Poly~ADP-Ribose!Polymerase in rat hepa-
tocytes does not contribute to their cell death by oxidative
stress. Exp Cell Res 254, 173–179.
Lau, C., Mole, M.L., Copeland, M.F., Rogers, J.M., Kavlock,
R.J., Suey, D.L., Cameron, A.M., Ellis, D.H., Logsdon, T.R.,
Merriman, J. & Setzer, R.W. ~2001!. Toward a biologically
based dose-response model for developmental toxicity of
5-fluorouracil in the rat: Acquisition of experimental data.
Toxicol Sci 59, 37–48.
Lee, Q., Park, H.W., Thayer, J., Mirkes, P.E. & Juchau, M.R.
~1996!. Apoptosis induced in cultured rat embryos by intra-
Apoptosis Assays 389
amniotically microinjected sodium nitroprusside. Teratology
53, 21–30.
Levin, S. ~1999!. The nomenclature of cell death: Recommenda-
tion of an ad hoc committee of the society of toxicological
pathologists. Toxicol Pathol 27, 484.
Lumsden, A., Sprawson, N. & Graham, A. ~1991!. Segmental
origin and migration of neural crest cells in the hindbrain
region of the chick embryo. Development 113, 1281–1291.
Majno, G. & Joris, I. ~1995!. Apoptosis, oncosis, necrosis: An
overview of cell death. Am J Pathol 146, 3.
Matsuyama, S. & Reed, J.C. ~2000!. Mitochondrial-dependent
apoptosis and cellular pH regulation. Cell Death Differ 7,
1155–1165.
Menkes, B., Prelipceanu, O. & Capalnasan, I. ~1979!. Vital
fluorochroming as a tool for embryonic cell death research. Adv
Study Birth Defects 3, 219–241.
Minamikawa, T., Sriratana, A., Williams, D.A., Bowser, D.N.,
Hill, J.S. & Nagley, P. ~1999!. Chloromethyl-X-rosamine ~Mito-
Tracker Red! photosensitizes mitochondria and induces apop-
tosis in intact human cells. J Cell Sci 112, 2419–2430.
Modak, S.P. & Bollum, F.J. ~1972!. Detection and measurement of
single-strand breaks in nuclear DNA in fixed lens sections. Exp
Cell Res 75, 307–313.
Nakamura, N., Fujioka, M. & Mori, C. ~2000!. Alterations of
programmed cell death and gene expression of 5-bromodeoxy-
uridine during limb development in mice. Toxicol Appl Pharma-
col 167, 100–106.
Narula, J., Haider, N., Virmani, R., DiSalvo, T.G., Kolodgie,
F.D., Hajjar, R.J., Schmidt, U., Semigran, M.J., Dec, G.W. &
Kwaw, B.-A. ~1996!. Apoptosis in myocytes in end-stage heart
failure. New Engl J Med 335, 1182–1189.
Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N.,
Kolodgie, F.D., Dal Bello, B., Semigran, M.J., Bielsa-
Masdeu, A., Dec, G.W., Isreals, S., Ballester, M., Virmani,
R., Saxena, S. & Kharbanda, S. ~1999!. Apoptosis in heart
failure: Release of cytochrome c from mitochondria and activa-
tion of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci
USA 96, 8144–8149.
Negoescu, A., Lorimier, P., Labat-Moleur, F., Drouet, C.,
Robert, C., Guillermet, C., Brambilla, C. & Brambilla, E.
~1996!. In situ apoptotic cell labeling by the TUNEL method:
Improvement and evaluation on cell preparation. J Histochem
Cytochem 44, 959–968.
Nicholson, D.W. ~2001!. Apoptosis. Baiting death inhibitors. Na-
ture 410, 33–34.
Nicholson, D.W. & Thornberry, N.A. ~1997!. Caspases: Killer
proteases. Trends Biochem Sci 22, 299–306.
Nieminen, A.-L., Byrne, A.M., Herman, B. & Lemasters, J.J.
~1997!. Mitochondrial permeability transition in hepatocytes
induced by t-BuOOH: NAD ~P! H and reactive oxygen species.
Am J Physiol 272, C1286–C1294.
Nieminen, A.-L., Saylor, A.K., Tesfair, S.A., Herman, B. &
Lemasters, J.J. ~1995!. Contribution of the mitochondrial per-
meability transition to lethal injury after exposure of hepato-
cytes to t-butylhydroperoxide. Biochem J 307, 99–106.
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W.,
Nitahara, J.A., Quaini, E., Di Loreto, C., Beltrami, C.A.,
Krajewski, S., Reed, J.C. & Anversa, P. ~1997!. Apoptosis in
the failing human heart. New Engl J Med 336, 1131–1141.
Packard, B.Z., Toptygin, D.D., Komoriya, A. & Brand, L. ~1997!.
The design of profluorescent protease substrates guided by
exciton theory. Methods Enzymol 278, 15–28.
Saraste, A. & Pulkki, K. ~2000!. Morphological and biochemical
hallmarks of apoptosis. Cardiovasc Res 45, 528–537.
Saunders, J.W., Jr. ~1966!. Death in embryonic systems. Science
154, 6104–6122.
Saunders, J.W., Jr. & Gasseling, M.T. ~1962!. Cellular death in
morphogenesis of the avian wing. Dev Biol 5, 147–148.
Schaper, J., Elsasser, A. & Kostin, S. ~1999!. The role of cell
death in heart failure. Circ Res 85, 867–869.
Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S. &
Peter, M.E. ~1998!. Apoptosis signaling by death receptors. Eur
J Biochem 254, 439–459.
Shi, Y. ~2001!. A structural view of mitochondria-mediated apop-
tosis. Nat Struct Biol 8, 394–401.
Sperandio, S. ~2000!. An alternative, nonapoptotic form of
programmed cell death. Proc Natl Acad Sci USA 97, 14376–
14381.
Sugrue, S.P. & Hay, E.D. ~1981!. Response of basal epithelial cell
surface and cytoskeleton to solubilized extracellular matrix
molecules. J Cell Biol 91, 45–54.
Sugrue, S.P. & Hay, E.D. ~1986!. The identification of extracellu-
lar matrix ~ECM! binding sites on the basal surface of embry-
onic corneal epithelium and the effects of ECM binding on
epithelial collagen production. J Cell Biol 102, 1907–1916.
Svoboda, K.K. ~1992!. Embryonic corneal epithelial actin alters
distribution in response to laminin. Ophthamol Vis Sci 33,
324–333.
Svoboda, K.K. & Hay, E.D. ~1987!. Embryonic corneal epithelial
interaction with exogenous laminin and basal lamina is F-actin
dependent. Dev Biol 123, 455–469.
Svoboda, K.K., Orlow, D.L., Chu, C.L. & Reenstra, W.R. ~1999!.
ECM stimulated actin bundle formation in embryonic corneal
epithelia is tyrosine phosphorylation dependent. Anat Rec 254,
348–359.
Taper, H.S., Jamison, J.M., Gilloteaux, J., Gwin, C.A., Gordon,
T. & Summers, J.L. ~2001!. In vivo reactivation of DNases
in implanted human prostate tumors after administration of
a vitamin C/K~3! combination. J Histochem Cytochem 49,
109–120.
Thompson, C.B. ~1995!. Apoptosis in the pathogenesis and treat-
ment of disease. Science 267, 1456–1462.
390 M. Watanabe et al.
Tzima, E., Trotter, P.J., Orchard, M.A. & Walker, J.H. ~1999!.
Annexin V binds to the actin-based cytoskeleton at the plasma
membrane of activated platelets. Exp Cell Res 251, 185–193.
Van den Eijnde, S.M., Boshart, L., Reutelingsperger, C.P.M.,
De Zeeuw, C.I. & Vermeij-Keers, C. ~1997a!. Phosphatidylser-
ine plasma membrane asymmetry in vivo: A pancellular phe-
nomenon which alters during apoptosis. Cell Death Differ 4,
311–316.
Van den Eijnde, S.M., Luijsterburg, A.J.M., Boshart, L., De
Zeeuw, C.I., van Dierendonck, J.H., Reutelingsperger,
C.P.M. & Vermeij-Keers, C. ~1997b!. In situ detection of apop-
tosis during embryogenesis with annexin V: From whole mount
to ultrastructure. Cytometry 29, 313–320.
van den Hoff, M.J.B., Van den Eijnde, S.M., Virágh, S. &
Moorman, A.F.M. ~2000!. Programmed cell death in the devel-
oping heart. Cardiovasc Res 45, 603–620.
Watanabe, M., Choudhry, A., Berlan, M., Singal, A., Siwik, E.,
Mohr, S. & Fisher, S.A. ~1998!. Developmental remodeling
and shortening of the cardiac outflow tract involves myocyte
programmed cell death. Development 125, 3809–3820.
Waterhouse, N.J. & Green, D.R. ~1999!. Mitochondria and apop-
tosis: HQ or high-security prison? J Clin Invest 19, 378–387.
Willingham, M.C. ~1999!. Cytochemical methods for the detec-
tion of apoptosis. J Histochem Cytochem 47, 1101–1109.
Wolf, B.B. & Green, D.R. ~1999!. Suicidal tendencies: Apoptotic
cell death by caspase family proteinases. J Biol Chem 274,
20049–20052.
Wyllie, A.H. & Golstein, P. ~2001!. More than one way to go.
Proc Natl Acad Sci USA 98, 11.
Wyllie, A.H., Kerr, J.F.R. & Currie, A.R. ~1980!. Cell death: The
significance of apoptosis. Int Rev Cytol 68, 251–306.
Yaoita, Y. & Nakajima, K. ~1997!. Induction of apoptosis and
cpp32 expression by thyroid hormone in a myoblastic cell line
derived from tadpole tail. J Biol Chem 272, 5122–5127.
Zakeri, Z. ~1998!. The study of cell death by the use of cellular
and developmental models. In When Cells Die: A Comprehen-
sive Evaluation of Apoptosis and Programmed Cell Death, Lock-
shin, R.A., Zakeri, Z. & Tilly, J.L. ~Eds.!. pp. 97–130. New York:
Wiley Liss.
Zakeri, Z.F., Quaglino, D. & Ahuja, H.S. ~1994!. Apoptotic cell
death in the mouse limb and its suppression in the Hammertoe
mutant. Dev Biol 165, 294–297.
Zhang, J.H. & Xu, M. ~2000!. DNA fragmentation in apoptosis.
Cell Res 10, 205–211.
Zhu, C., Wang, X., Hagberg, H. & Blomgren, K. ~2000!. Corre-
lation between caspase-3 activation and three different markers
of DNA damage in neonatal cerebral hypoxia-ischemia. J Neuro-
chem 75, 819–829.
Zucker, R.M., Hunter, E.S., 3rd & Rogers, J.M. ~1999!. Apopto-
sis and morphology in mouse embryos by confocal laser scan-
ning microscopy. Methods 18, 473–480.
Zucker, R.M., Hunter, E.S., 3rd & Rogers, J.M. ~2000a!. Confo-
cal laser scanning microscopy of morphology and apoptosis in
organogenesis-stage mouse embryos. Methods Mol Biol 135,
191–202.
Zucker, R.M., Hunter, S. & Rogers, J.M. ~1998!. Confocal laser
scanning microscopy of apoptosis in organogenesis-stage mouse
embryos. Cytometry 33, 348–354.
Zucker, R.M., Keshaviah, A.P., Price, O.T. & Goldman, J.M.
~2000b!. Confocal laser scanning microscopy of rat follicle
development. J Histochem Cytochem 48, 781–791.
Zucker, R.M. & Price, O.T. ~1999!. Practical confocal microscopy
and the evaluation of system performance. Methods 18, 447–
458.
Apoptosis Assays 391